-
Robert F. Kennedy Jr.'s nomination as Health Secretary has led to significant stock declines in vaccine and pharmaceutical companies. His history of vaccine skepticism raises concerns about regulatory changes and investment in the biotech sector, particularly affecting companies like Moderna and Pfizer.
-
President-elect Donald Trump has nominated Robert F. Kennedy Jr. as Secretary of Health and Human Services, raising significant concerns among public health experts due to Kennedy's controversial views on vaccines and public health. His appointment could reshape U.S. health agencies, including the FDA and CDC, as he aims to promote transparency and address chronic diseases.
-
Matt Gaetz, recently nominated by Donald Trump for Attorney General, resigned from Congress amid ongoing investigations into allegations of sexual misconduct. His resignation has raised concerns about the implications for his confirmation process, with bipartisan calls for transparency regarding the allegations against him.
-
Robert F. Kennedy Jr. has been nominated by President-elect Donald Trump as the Secretary of Health and Human Services. His history of anti-vaccine advocacy raises concerns among public health experts about potential impacts on vaccination rates and public health policy in the U.S.